Skip to main content
SpringerLink
Log in

Methyl-deficient diets, methylated ER genes and breast cancer: An hypothesized association

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Recent molecular studies show that ER-negative breast cancer results from the lack of ER gene transcription due to the methylation of the CpG island 5′ to the gene. Because CpG island methylation is an early event in carcinogenesis and because methyl- deficient diets could result in CpG island methylation, it is relevant to postulate that methyl-deficient diets may be a risk factor for breast cancer with methylated ER genes (as opposed to the disease with unmethylated ER genes). This molecular-based etiologic hypothesis may facilitate epidemiological research on the relationship between breast cancer and diet that has been unclear until now.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hildreth NG, Kelsey JL, Eisenfeld AJ, LiVolsi VA, Holford TR, Fischer DB. Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst 1983; 70: 1027–31.

    Google Scholar 

  2. Hislop TG, Coldman AJ, Elwood JM, Skippen DH, Kan L. Relationship between risk factors for breast cancer and hormonal status. Int J Epidemiol 1986; 15: 469–76.

    Google Scholar 

  3. McTiernan A, Thomas DB, Johnson LK, Roseman D. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst 1986; 77: 849–54.

    Google Scholar 

  4. Stanford JL, Szklo M, Boring CC, Brinton LA, Diamond EA, Greenberg RS, et al. A case-control study of breast cancer stratified by estrogen receptor status. Am J Epidemiol 1987; 125: 184–94.

    Google Scholar 

  5. Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD. Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 1989; 59: 119–25.

    Google Scholar 

  6. Kreiger N, King WD, Rosenberg L, Clarke EA, Palmer JR, Shapiro S. Steroid receptor status and the epidemiology of breast cancer. Ann Epidemiol 1991; 1: 513–23.

    Google Scholar 

  7. Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, et al. A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status. Cancer Causes Control 1993; 4: 39–44.

    Google Scholar 

  8. Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995; 4: 319–26.

    Google Scholar 

  9. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 1994; 54: 2552–5.

    Google Scholar 

  10. Ferguson AT, Lapidus RG, Baylin SB, Davidson NE. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res 1995; 55: 2279–83.

    Google Scholar 

  11. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev 1995; 5: 309–14.

    Google Scholar 

  12. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular biology of the cell (3rd edition). New York: Garland Publisher, 1994.

    Google Scholar 

  13. Vertino PM, Issa JP, Pereira-Smith OM, Baylin SB. Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts. Cell Growth Diff 1994; 5: 1395–1402.

    Google Scholar 

  14. Issa JPJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536–40.

    Google Scholar 

  15. Vertino PM, Spillare EA, Harris CC, Baylin SB. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. Cancer Res 1993; 53: 1684–9.

    Google Scholar 

  16. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 1992; 89: 1929–33.

    Google Scholar 

  17. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992; 52: 6079–82.

    Google Scholar 

  18. Weigel RJ, deConinck EC. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 1993; 53: 3472–4.

    Google Scholar 

  19. Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD, et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 1995; 87: 446–51.

    Google Scholar 

  20. Piva R, Rimondi AP, Hanau S, Maestri I, Alvisi A, Kumar VL, et al. Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor. Br J Cancer 1990; 61: 270–5.

    Google Scholar 

  21. Piva R, Kumar LV, Hanau S, Maestri I, Rimondi AP, Pansini SF, et al. The methylation pattern in the 5′ end of the human estrogen receptor gene is tissue specific and related to the degree of gene expression. Biochem Int 1989; 19: 267–75.

    Google Scholar 

  22. Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, et al. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 1998; 58: 2515–9.

    Google Scholar 

  23. Issa JPJ, Baylin SB, Belinsky SA. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res 1996; 56: 3655–8.

    Google Scholar 

  24. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willet WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995, 87: 265–73.

    Google Scholar 

  25. Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet 1994; 1487–95.

  26. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141–96.

    Google Scholar 

  27. Pogribny IP, Miller BJ, James SJ. Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat. Cancer Lett 1997; 115: 31–8.

    Google Scholar 

  28. Jacob RA, Pianalto FS, Henning SM, Zhang JZ, Swendseid ME. In vivo methylation capacity is not impaired in healthy men during short-term dietary folate and methyl group restriction. J Nutr 1995; 125: 1495–502.

    Google Scholar 

  29. Mostoslavsky R, Bergman Y. DNA methylation: regulation of gene expression and role in the immune system. Biochim Biophys Acta 1997; 1333: F29–F50.

    Google Scholar 

  30. Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, et al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996; 56: 973–7.

    Google Scholar 

  31. Shivapurkar N, Poirier LA. Tissue levels of S-adenosylmethionine and S-adenosylhomocysteine in rats fed methy-deficient, amino acid-defined diets for one to five weeks. Carcinogenesis 1983; 4: 1051–7.

    Google Scholar 

  32. Wainfan E, Poirier LA. Methylation groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 1992; 52 (7 Suppl): 2071S–7S.

    Google Scholar 

  33. Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994; 48: 137–52.

    Google Scholar 

  34. Cooper AJ. Biochemistry of sulfur-containing amino acids. Ann Rev Biochem 1983; 52: 187–222.

    Google Scholar 

  35. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985; 228: 187–90.

    Google Scholar 

  36. Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, Selhub J, et al. Folate dificiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 1992; 52: 5002–6.

    Google Scholar 

  37. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991; 20: 368–74.

    Google Scholar 

  38. Baron JA, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 1998; 90: 57–62.

    Google Scholar 

  39. Kluijtmans LAJ, Kastelein JJP, Lindemans J, Boers GHJ, Hail SG, Bruschke AVG, et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997; 96: 2573–7.

    Google Scholar 

  40. Arai K, Yamasaki Y, Kajimoto Y, Watada H, Umayahara Y, Kodama M, et al. Association of metheylenetetrahydrofolate reductase gene polymorphism with caroid arterial wall thickening and myocardial infarction risk in NIDDM. Diabetes 1997; 46: 2102–4.

    Google Scholar 

  41. Schneider JA, Rees DC, Liu YT, Clegg JB. World distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998; 62: 1258–60.

    Google Scholar 

  42. Frost P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthewes RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–3.

    Google Scholar 

  43. Jacques PF, Boston AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7–9.

    Google Scholar 

  44. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862–4.

    Google Scholar 

  45. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098–102.

    Google Scholar 

  46. Schatzkin A, Goldstein A, Freedman LS. What does it mean to be a cancer gene carrier? Problems in establishing causality from the molecular genetic of cancer. J Natl Cancer Inst 1995; 87: 1126–30.

    Google Scholar 

  47. Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst 1990; 82: 561–9.

    Google Scholar 

  48. Franceschi S, Favero A, La Vecchia C, Negri E, Dal Maso L, Salvini S, et al. Influence of food groups and food diversity on breast cancer risk in Italy. Int J Cancer 1995; 63: 785–9.

    Google Scholar 

  49. Trichopoulou A, Katsouyanni K, Stuver S, Tzala L, Gnardellis C, Rimm E, et al. Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst 1995; 87: 110–6.

    Google Scholar 

  50. Freudenheim JL, Marchall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996; 88: 340–8.

    Google Scholar 

  51. Braga C, La Vecchia C, Negri E, Franceschi S, Parpinel M. Intake of selected foods and nutrients and breast cancer risk: an age-and menopause-specific analysis. Nutr Cancer 1997; 28: 258–63.

    Google Scholar 

  52. Negri E, La Vecchia C, Franceschi S, D'Avanzo B, Parazzini F. Vegetable and fruit consumption and cancer risk. Int J Cancer 1991; 48: 350–4.

    Google Scholar 

  53. Potischman N, Weiss HA, Swanson CA, Coates RJ, Gammon MD, Malone KE, et al. Diet during adolescence and risk of breast cancer among young women. J Natl Cancer Inst 1998; 90: 226–33.

    Google Scholar 

  54. Rosenberg L, Metzger LS, Palmer JR. Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence. Epidemiol Rev 1993; 15: 133–44.

    Google Scholar 

  55. Bowlin SJ, Leske MC, Varma A, Nasca P, Weinstein A, Caplan L. Breast cancer risk and alcohol consumption: results from a large case-control study. Int J Epidemiol 1997; 26: 915–23.

    Google Scholar 

  56. Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, et al. Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomark Prev 1998; 7: 359–64.

    Google Scholar 

  57. Bossuyt PMM. Putting genes into modern epidemiology: `Nature-nurture' and beyond. Epidemiology 1997; 8: 2–5.

    Google Scholar 

  58. Hayes RB. Biomarkers in occupational cancer epidemiology: considerations in study design. Environ Health Perspect 1992; 98: 149–54.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive and Occupational Medicine, School of Medicine, Meharry Medical College, Nashville, Tennessee, USA

    Kangmin Zhu

  2. Department of Microbiology, School of Medicine, Meharry Medical College, Nashville, Tennessee, USA

    Scott M. Williams

Authors
  1. Kangmin Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott M. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, K., Williams, S.M. Methyl-deficient diets, methylated ER genes and breast cancer: An hypothesized association. Cancer Causes Control 9, 615–620 (1998). https://doi.org/10.1023/A:1008819210777

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008819210777

Search

Navigation